Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Healthcare Sector Analysis

UpdatedFeb 26, 2026
DataAggregated Company Financials
Companies16
  • 7D1.5%
  • 3M-3.1%
  • 1Y25.4%
  • YTD5.0%

The Healthcare industry is up 1.5% in the last week, with Rede D'Or São Luiz up 1.6%. In the same time, Oncoclínicas do Brasil Serviços Médicos was down 8.4%. In the last 12 months, the industry was up 25%. Earnings are forecast to grow by 24% annually.

Sector Valuation and Performance

Has the Brazilian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 27 Feb 2026R$151.1bR$152.1bR$1.8b13.9x81.8x1x
Sun, 25 Jan 2026R$153.1bR$152.1bR$1.8b13x83x1x
Tue, 23 Dec 2025R$144.6bR$152.1bR$1.8b11.8x78.3x1x
Thu, 20 Nov 2025R$152.0bR$152.1bR$1.9b12.5x81.7x1x
Sat, 18 Oct 2025R$148.0bR$149.9bR$2.5b11.8x59.3x1x
Mon, 15 Sep 2025R$149.2bR$149.9bR$2.5b12.4x59.8x1x
Wed, 13 Aug 2025R$142.1bR$151.5bR$2.0b11.7x70.5x0.9x
Fri, 11 Jul 2025R$135.2bR$149.5bR$2.0b11x66.3x0.9x
Sun, 08 Jun 2025R$142.6bR$149.5bR$2.0b10.7x69.9x1x
Tue, 06 May 2025R$129.9bR$147.7bR$1.9b11.3x70x0.9x
Thu, 03 Apr 2025R$118.6bR$150.7bR$3.6b10.5x33.2x0.8x
Sat, 01 Mar 2025R$117.0bR$146.6bR$4.7b10.7x25.1x0.8x
Mon, 27 Jan 2025R$116.2bR$146.7bR$4.7b10.8x24.9x0.8x
Wed, 25 Dec 2024R$112.1bR$146.7bR$4.7b11x24x0.8x
Fri, 22 Nov 2024R$128.5bR$148.2bR$5.2b13.8x24.5x0.9x
Sun, 20 Oct 2024R$141.3bR$144.9bR$4.4b11.6x32.1x1x
Tue, 17 Sep 2024R$163.3bR$144.9bR$4.4b12x37.1x1.1x
Thu, 15 Aug 2024R$153.2bR$144.5bR$4.1b12x37.4x1.1x
Sat, 13 Jul 2024R$147.1bR$142.9bR$4.2b11.9x35.2x1x
Mon, 10 Jun 2024R$139.1bR$142.9bR$4.2b11.4x33.2x1x
Wed, 08 May 2024R$150.0bR$141.1bR$3.7b12.3x40.2x1.1x
Fri, 05 Apr 2024R$143.7bR$140.0bR$3.2b12.5x45.3x1x
Sun, 03 Mar 2024R$146.7bR$132.8bR$2.7b16.7x53.9x1.1x
Tue, 30 Jan 2024R$155.1bR$135.0bR$2.9b17.2x53.8x1.1x
Thu, 28 Dec 2023R$170.0bR$135.0bR$2.9b21x59x1.3x
Sat, 25 Nov 2023R$160.5bR$135.0bR$2.9b18.7x55.6x1.2x
Mon, 23 Oct 2023R$146.2bR$126.1bR$2.7b18.1x53.2x1.2x
Wed, 20 Sep 2023R$167.6bR$126.1bR$2.7b19.8x61x1.3x
Fri, 18 Aug 2023R$179.4bR$126.1bR$2.7b20.5x65.3x1.4x
Sun, 16 Jul 2023R$181.4bR$116.7bR$2.8b16.7x64.4x1.6x
Tue, 13 Jun 2023R$180.7bR$116.7bR$2.8b17.2x63.8x1.5x
Thu, 11 May 2023R$142.2bR$106.6bR$3.3b14.9x43.3x1.3x
Sat, 08 Apr 2023R$130.0bR$106.3bR$3.3b14.2x39.1x1.2x
Mon, 06 Mar 2023R$139.0bR$102.7bR$3.8b14x36.8x1.4x
Price to Earnings Ratio

36.8x


Total Market Cap: R$139.0bTotal Earnings: R$3.8bTotal Revenue: R$102.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Sector Price to Earnings3Y Average 50.9x202420252026
Current Industry PE
  • Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 81.8x which is higher than its 3-year average PE of 50.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 21% per year over the last three years.
  • Meanwhile revenues for these companies have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare sector?

BR Market2.29%
Healthcare1.55%
Medical Equipment11.29%
Pharma3.45%
Healthcare Services1.33%
Biotech0.25%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 116x.
    • Analysts are expecting annual earnings growth of 23.8%, which is higher than its past year's earnings growth of 7.1% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 0.80x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 29% over the next 5 years.
  • This is better than its past earnings growth rate of 5.4% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ODPV3 OdontoprevR$12.853.7%
+R$250.7m		18.3%PE12.2x
AALR3 Alliança Saúde e ParticipaçõesR$5.2426.3%
+R$166.0m		-56.8%PS0.6x
MATD3 Hospital Mater DeiR$6.147.3%
+R$139.9m		65.5%PE25.1x
ONCO3 Oncoclínicas do Brasil Serviços MédicosR$2.703.8%
+R$111.4m		-46.6%PS0.5x
PFRM3 Profarma Distribuidora de Produtos FarmacêuticosR$9.165.3%
+R$56.4m		38.6%PE9.7x

Latest News

OFSA3
R$24.02
Ouro Fino Saúde Animal Participações
7D
2.4%
1Y
34.7%
RDOR3
R$41.55
Rede D'Or São Luiz
7D
-6.9%
1Y
48.4%
BLAU3
R$10.97
Blau Farmacêutica
7D
-2.5%
1Y
13.2%
FLRY3
R$17.24
Fleury
7D
-4.0%
1Y
55.0%

FLRY3: Investor Day Plans Will Still Offer Limited Upside Potential

Analysts have slightly adjusted their view on Fleury, with the implied fair value holding at about R$14.25. Small tweaks to revenue growth, profit margin and future P/E assumptions reflect a marginally refined outlook rather than a major change in direction.
PFRM3
R$9.16
Profarma Distribuidora de Produtos Farmacêuticos
7D
5.3%
1Y
38.6%
HAPV3
R$10.75
Hapvida Participações e Investimentos
7D
-0.4%
1Y
-66.2%

HAPV3: Index Reclassification Will Support Future Upside From Lower Expected P/E

Analysts have trimmed their price target for Hapvida Participações e Investimentos from R$18.50 to R$15.00, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations in their valuation work. What's in the News Hapvida Participações e Investimentos S.A. has been added to the Brazil Small Cap Index, which can affect how index funds and small cap mandates gain exposure to the stock (Key Developments).
ODPV3
R$12.85
Odontoprev
7D
3.7%
1Y
18.3%
ONCO3
R$2.70
Oncoclínicas do Brasil Serviços Médicos
7D
3.8%
1Y
-46.6%

ONCO3: Lower Margin Outlook Will Likely Limit Future Share Returns

Analysts have raised their price target for Oncoclínicas do Brasil Serviços Médicos, citing updated assumptions that include a fair value shift from R$1.50 to R$1.60, a lower discount rate, slightly adjusted revenue growth and profit margin expectations, and a modestly higher future P/E multiple. What's in the News Oncoclínicas do Brasil Serviços Médicos S.A. has scheduled a Special and Extraordinary Shareholders Meeting for January 7, 2026.
BIOM3
R$6.30
Biomm
7D
1.6%
1Y
-37.0%

We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt

Feb 09
We Think Biomm (BVMF:BIOM3) Has A Fair Chunk Of Debt
DASA3
R$4.07
Diagnósticos da América
7D
-2.6%
1Y
140.8%
AALR3
R$5.24
Alliança Saúde e Participações
7D
26.3%
1Y
-56.8%
MATD3
R$6.14
Hospital Mater Dei
7D
7.3%
1Y
65.5%
QUAL3
R$2.45
Qualicorp Consultoria e Corretora de Seguros
7D
-5.4%
1Y
36.1%
VVEO3
R$1.62
CM Hospitalar S/A
7D
2.5%
1Y
19.1%